Optiver Holding
VYGR icon

Optiver Holding’s Voyager Therapeutics VYGR Stock Holding History

Optiver Holding’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$553 Sell
158
-288
-65% -$1.09K ﹤0.01% 2564
2026
Q1 		$1.72K Sell
446
-192
-30% -$756 ﹤0.01% 1908
2025
Q4 		$2.51K Hold
638
– – ﹤0.01% 1881
2025
Q3 		$2.98K Buy
+638
New +$2.31K ﹤0.01% 2188

Other funds holding VYGR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Optiver Holding's VYGR Position: Q2 2026 in Review

Optiver Holding reduced its Voyager Therapeutics (VYGR) stake by 65% in Q2 2026, selling an estimated $1.09K and leaving 158 shares worth $553. The position accounts for ﹤0.01% of the portfolio, ranked #2564.

Optiver Holding first reported a position in VYGR in Q3 2025 and has held it in 4 quarters since. The position peaked at $2.98K in Q3 2025. 135 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

  • Optiver Holding held 158 shares of Voyager Therapeutics worth $553 as of Q2 2026.
  • Optiver Holding sold 288 Voyager Therapeutics shares in Q2 2026, an estimated $1.09K.
  • Voyager Therapeutics made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #2564 holding.
  • Optiver Holding first reported a position in Voyager Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • Optiver Holding's Voyager Therapeutics position peaked at $2.98K in Q3 2025.
  • 135 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.